Cochlear Limited (ASX: COH) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Cochlear Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Cochlear Limited (ASX: COH)
Latest News
Growth Shares
3 quality ASX shares to make you rich
Share Gainers
ALL ORDINARIES finishes higher Friday: 8 shares you missed
Share Gainers
Here's why Goldman Sachs just upgraded Cochlear shares to a 'buy'
Growth Shares
Where to invest $10,000 in ASX 200 shares in May
Share Market News
Feeble CPI data has investors upping bets on an RBA rate cut within months
Share Market News
Can the Cochlear share price reach $200 again?
Share Market News
Top brokers name 3 ASX shares to buy today
Share Gainers
Can the Cochlear share price go even higher?
Share Market News
5 things to watch on the ASX 200 on Wednesday
Share Gainers
ALL ORDINARIES finishes higher Tuesday: 8 shares you missed
Share Gainers
Why a2 Milk, Automotive Holdings, Cochlear, & Nearmap shares stormed higher today
Share Gainers
Cochlear share price jumps higher on new implant announcement
Frequently Asked Questions
-
Yes, Cochlear Ltd has historically paid two fully franked dividends a year.
-
Cochlear Ltd generally pays its dividends in April and October.
-
Cochlear Ltd listed on the ASX on 4 December 1995.
COH ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Cochlear Limited
Cochlear Ltd (ASX: COH) is the world's leading cochlear implant device manufacturer with around half of global market share.
The company was founded in Australia in 1983 to commercialise implants pioneered by Melbourne researcher Dr Graeme Clark, but later became a separate entity.
Developed markets contribute the bulk of Cochlear's group revenue with cochlear implants the standard of care for children with severe to profound hearing loss. The company is also catering for a growing cohort of seniors when standard hearing aid technology loses its effectiveness.
Cochlear's main products include cochlear implants, bone-anchored hearing devices, and associated sound processors. The vast majority of Cochlear's revenue is derived from overseas, with the US and Europe by far the company's two largest markets.
